pone.0293700.s001.pdf (36.23 kB)
Cancer vs non-tumor tissue expression of TFRC from the GENT2 database; P value for T-test of cancer vs non-cancer and Log 2 of fold-change (Log2 FC).
journal contribution
posted on 2023-12-20, 18:36 authored by Francesca Fontana, Alison K. Esser, Christopher Egbulefu, Partha Karmakar, Xinming Su, John S. Allen, Yalin Xu, Jennifer L. Davis, Ariel Gabay, Jingyu Xiang, Kristin A. Kwakwa, Brad Manion, Suzanne Bakewell, Shunqiang Li, Haeseong Park, Gregory M. Lanza, Samuel Achilefu, Katherine N. WeilbaecherCancer vs non-tumor tissue expression of TFRC from the GENT2 database; P value for T-test of cancer vs non-cancer and Log 2 of fold-change (Log2 FC).
History
Usage metrics
Categories
Keywords
xlink "> conjugationtumor burden relativesystemic iron chelationdedicated tissue microarraysbiomaterials often depends60 – 85post chemotherapy tumorstarget breast cancerxlink "> tfrproved transferrin localizationevaluate matched primarymetastatic breast cancerenhanced tfr uptakebreast cancerneoadjuvant chemotherapytfr suggestsvivo use transferrintwelve publiclytransferrin receptortfrc tfr expressiontargeted receptorstaining intensityscore ).promising strategynanotherapeutic agentsmetastatic sitesincluding metastasesimprove uptakederived xenograftsbone metastasesbest candidatesavailable datasetsapproved mrq48 antibody
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC